PHPRF (Primary Health Properties) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


PHPRF Primary Health Properties PLC PHPRF
61 GF Score
Price $1.27
GF Value $3.31
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Primary Health Properties Research & Development?

Primary Health Properties PHPRF 61 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates PHPRF with a GF Score™ of 61/100 and a GF Value™ of $3.31 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Primary Health Properties's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Primary Health Properties  (OTCPK:PHPRF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Primary Health Properties Research & Development Related Terms

Primary Health Properties Research & Development Historical Data

* Premium members only.

The historical data trend for Primary Health Properties's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Primary Health Properties Research & Development Chart

Primary Health Properties Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Primary Health Properties Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PHPRF
61GF Score
Primary Health Properties PLC PHPRF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Primary Health Properties Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Primary Health Properties (PHPRF) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Primary Health Properties and its competitors.
Is Primary Health Properties' Research & Development too high?
Primary Health Properties' current Research & Development is $0.0 Mil. Overall, Primary Health Properties has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Primary Health Properties' Research & Development compare to WELL and VTR?
Primary Health Properties' Research & Development of $0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Primary Health Properties and its competitors. Primary Health Properties's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Primary Health Properties stock overvalued right now?
Based on GuruFocus' analysis, Primary Health Properties (PHPRF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.31, compared to a current price of $1.27 — trading 61.6% below its estimated fair value. The current Research & Development is $0.0 Mil. Primary Health Properties' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Primary Health Properties (PHPRF), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Primary Health Properties (PHPRF) Overvalued in 2026?

Based on GuruFocus' analysis, Primary Health Properties stock appears to be undervalued. The current stock price of $1.27 is trading 61.6% below its estimated GF Value™ of $3.31. GuruFocus considers Primary Health Properties to be Possible Value Trap.

Key valuation signals for PHPRF:

  • Research & Development: $0.0 Mil
  • GF Value™: $3.31 vs. price of $1.27 (61.6% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the PHPRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Primary Health Properties Business Description

Industry Real EstateREITs
Address 15-16 Buckingham Street, 5th Floor, Burdett House, London, GBR, WC2N 6DU
Primary Health Properties PLC is a UK-based real estate investment trust. The company is engaged in making investments in integrated healthcare properties. Its services include Acquisition and development, Property management, Landlord and tenant, Asset management, and Finance. It seeks the generation of rental income and capital growth through investment in primary healthcare property in the United Kingdom and Ireland. It receives rental income on property investments.
61GF Score

Get the complete analysis for PHPRF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.27
Price
$3.31
GF Value